MilliporeSigma receives $136.7 million federal contract for new Sheboygan production facility
MilliporeSigma, the U.S. and Canada life science business of Germany-based Merck, has received a $136.7 million federal contract for a new facility in Sheboygan that will produce a key ingredient used in rapid diagnostic test kits for COVID-19 and other infectious diseases.
To access this post, you must purchase Premium Subscription - Daily Email and Full Website Access.